Study: E-cigarette Aerosol Enhances Optical Imaging of Lung Tissue

Nov.24.2023

Russian researchers from Saratov and Tomsk universities have found that e-cigarette aerosols can enhance lung tissue contrast, potentially improving accuracy in diagnosing lung diseases.

According to a report from ABnews, research teams from two state universities in Saratov and Tomsk, Russia have recently published a study in the journal Diagnostics. The study suggests that aerosols in e-cigarettes can enhance the optical imaging contrast in lung tissue, offering the potential to improve the accuracy of diagnosing lung diseases.

This experiment simulated the use of e-cigarettes and was conducted on rats. It found that the morphology of lung tissue formation is altered by the inhalation of e-cigarette aerosol, affecting its gas exchange capabilities.

References:

[1] Российские ученые нашли применение вейпам в медицине

Also Read:

[1] Study Shows Nicotine Pouches Cannot Relieve Nicotine Addiction

[2] Yale University: Influence of Social Media on Teen E-cigarette Use

[3] E-cigarette Use Surpasses Traditional Cigarette Smoking Among American Youth

[4] E-cigarette Use Increases Asthma Risk in Adolescents

#E-cigarette #E-cigarettes and Tobacco #Research Study

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FCTC: Global tobacco control treaties to address nicotine addiction, tobacco’s impact on the environment and illicit tobacco trade

More than 1,400 delegates will gather in Geneva as two major global tobacco control treaties convene to address rising nicotine addiction, environmental harms, and illicit tobacco trade—key discussions that could shape the future of global tobacco control policy.

Nov.14

Product | Three Power Levels + “2+10” Setup: ELFBAR JoinOne Series Launches in UK Retail

ELFBAR rolls out the JoinOne15 Classic prefilled replaceable-pod kit, now listed across multiple UK e-commerce channels (some pages marked “coming soon”). The device uses a “2 ml prefilled pod + 10 ml refill container (‘2+10’)” system, supports three power levels, and claims up to 15,000 puffs in combined use. The kit is priced at £12.99, with matching “2+10” refill pods at £7.99.

Nov.03 by 2FIRSTS.ai

Nicoventures Granted Rehearing After Philip Morris Challenge Rejected

Nicoventures Trading Ltd., a subsidiary of British American Tobacco (BAT), has won an appeal at the European Patent Office (EPO), convincing the appellate board that examiners had violated its right to be heard by failing to review all of its submissions.

Dec.09 by 2FIRSTS.ai

Lancet Study Finds Rising Use of Nicotine Pouches in Britain

A study published in The Lancet has found that nicotine pouch use is increasing in Britain, particularly among young men. Usage among people aged 16 to 24 has risen sharply since early 2022.